SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

20 Dec 2019 07:00

RNS Number : 5669X
Warpaint London PLC
20 December 2019
 

20 December 2019

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Trading Update

 

Change of Executive Director Positions

 

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, provides an update on the trading performance for the year ending 31 December 2019 and announces a splitting of the positions of the Joint Chief Executives.

 

Trading Update

 

The Company's board is pleased to announce that it currently anticipates that Group sales for the financial year to 31 December 2019 will be approximately £50 million, in line with the guidance provided in the Company's trading update on 6 August 2019.

 

As the Company has previously outlined, a number of factors, including the geographic mix of sales, adverse exchange rate movements and the Group's investment in its strategy for future growth, particularly in the US, are having an impact on profitability in the current financial year. Consequently, the Company's board currently expects adjusted profit before tax for the year ending 31 December 2019 (excluding amortisation in connection with acquisitions, share incentive scheme costs and exceptional items, which the board expects to total approximately £2.8 million) will now be in the range of £5.1 million to £5.5 million.

 

Exchange rate movements in recent months have had a negative impact of approximately £250,000, from a translational perspective, on profitability since the Company's last update in September 2019. This, coupled with further negative margin impact, has led to this reduction in the expected adjusted profit before tax for the current financial year from the previously anticipated range of £6 million to £7 million.

 

Change of Executive Director Positions

 

Following a review of the senior roles within the Company it has been decided that from 1 January 2020 the positions of the Joint Chief Executives will be split, with Sam Bazini remaining as Chief Executive and Eoin Macleod being appointed to the newly created position of Managing Director, reflecting his more operational focus. Both Sam Bazini and Eoin Macleod remain significant shareholders and as executive directors of the Company on its board.

 

Commenting, Clive Garston, Chairman of Warpaint, said: "I am pleased that we anticipate reporting sales for the current financial year in line with the guidance we provided in August. Whilst the unprecedented volatility in exchange rates in recent months has had a negative impact on the profits of the Company, both from a translational and margin perspective, I am pleased by our overall trading performance.

 

"Following a review of the roles being undertaken by our Joint Chief Executives we have decided to formally split the role. Sam and Eoin have always split the Chief Executive role so that they have distinct responsibilities within the Company, but with the Company's growth and diversification since admission to AIM we think these new positions are now an appropriate way to formally reflect this.

 

"With the Company's robust balance sheet, profitable trading performance and strategy for growth we continue to look forward to the new year with confidence."

 

Enquiries:

 

Warpaint London

Sam Bazini - Joint Chief Executive Officer

Eoin Macleod - Joint Chief Executive Officer

Neil Rodol - Chief Financial Officer

c/o IFC

 

 

Shore Capital (Nominated Adviser and Joint Broker)

Antonio Bossi - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

020 7408 4090

N+1 Singer (Joint Broker)

Shaun Dobson - Corporate Finance

Alex Bond - Corporate Finance

Mia Gardner - Corporate Broking

020 7496 3000

 

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

020 3934 6630

 

 

 

 

 

Warpaint London plc

 

Warpaint London plc is made up of two divisions.

 

The largest division sells cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to discount retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and the rest of Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using the smaller brand names of Man'stuff, Body Collection, Vintage, Outdoor Girl, Very Vegan, Chit Chat, Smooch, Copy Cat and Taxi.

 

The second division trades in close-out and excess stock of other branded cosmetics and fragrances from around the world.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFUFUUFUSEDE
Date   Source Headline
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing
27th Jun 202211:34 amRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
31st May 20227:00 amRNSNotice of AGM and Posting of Annual Report
26th Apr 20223:57 pmRNSDividend Timetable
26th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12th Apr 20227:00 amRNSTrading Update and Notice of Results
21st Mar 20221:21 pmRNSHolding(s) in Company
11th Mar 20225:23 pmRNSPMDR / PCA Dealing
2nd Mar 20227:00 amRNSWard & Hagon Contract Renewal and Grant of Options
28th Feb 20224:29 pmRNSHolding(s) in Company
23rd Feb 20224:56 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSFull Year Trading Update
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSInterim Results
16th Sep 202112:16 pmRNSPrice Monitoring Extension
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSNotice of Results & Investor Webinar
3rd Aug 20217:00 amRNSAppointment of Non-Executive Director
11th Jun 202111:24 amRNSResult of AGM
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSAGM Statement
28th May 202111:01 amRNSTotal Voting Rights
25th May 20213:28 pmRNSGrant of Options and Director/PDMR Shareholding
17th May 202112:34 pmRNSNotice of AGM and Posting of Annual Report
6th May 20213:57 pmRNSExercise of share options, issue of equity and TVR
28th Apr 20217:00 amRNSResults for the year ended 31 December 2020
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSTrading Update and Notice of Results
19th Apr 20212:26 pmRNSHolding(s) in Company
8th Mar 20214:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.